Bartram Alexander, Gilbert Fiona, Thompson Alastair, Mann G Bruce, Agrawal Amit
University of Cambridge, School of Clinical Medicine, Cambridge, CB2 0SP, UK.
University of Cambridge, Department of Radiology, Box 218, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK.
Cancer Treat Rev. 2021 Mar;94:102158. doi: 10.1016/j.ctrv.2021.102158. Epub 2021 Feb 2.
The impact of MRI on improving surgical outcomes in DCIS is debated. Here, we explore the utility of MRI in the investigation and management of DCIS in three key areas. Firstly, we highlight that MRI is likely to be a more accurate predictor of actual tumour size than conventional imaging. Secondly, we examine mastectomy rates and reoperation rates across the literature and suggest that surgical outcomes do not differ between pre-operative MRI and conventional imaging groups, despite improved size estimation on MRI. Finally, we examine the rapidly developing field of oncoplastic breast surgery and highlight a paucity of data in determining the usefulness of pre-operative MRI in this field, despite this being an oncologically safe alternative with improved patient outcomes and satisfaction.
MRI对改善导管原位癌(DCIS)手术效果的影响存在争议。在此,我们在三个关键领域探讨MRI在DCIS的检查和治疗中的效用。首先,我们强调MRI可能比传统成像更能准确预测实际肿瘤大小。其次,我们研究了文献中的乳房切除术率和再次手术率,并指出尽管MRI对肿瘤大小的估计有所改善,但术前MRI组和传统成像组的手术效果并无差异。最后,我们研究了快速发展的肿瘤整形乳房手术领域,并强调尽管这是一种肿瘤学上安全的替代方法,能改善患者的治疗效果和满意度,但在确定术前MRI在该领域的效用方面缺乏数据。